BR100 Increased By (0.52%)
BR30 Increased By (0.44%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.58%)
BECO 5.67 Decreased By ▼ -0.06 (-1.05%)
BML 57.05 Decreased By ▼ -0.25 (-0.44%)
BOP 36.85 Increased By ▲ 0.08 (0.22%)
CNERGY 8.32 Decreased By ▼ -0.07 (-0.83%)
DCL 11.90 Decreased By ▼ -0.14 (-1.16%)
FCCL 58.66 Increased By ▲ 0.05 (0.09%)
FCSC 5.09 Increased By ▲ 0.08 (1.6%)
FFL 18.12 Increased By ▲ 0.18 (1%)
FNEL 1.26 No Change ▼ 0.00 (0%)
HUMNL 11.28 Decreased By ▼ -0.14 (-1.23%)
KEL 8.24 Decreased By ▼ -0.05 (-0.6%)
KOSM 6.54 Decreased By ▼ -0.08 (-1.21%)
MLCF 107.17 Decreased By ▼ -1.12 (-1.03%)
NBP 208.80 Increased By ▲ 2.76 (1.34%)
PACE 11.18 Increased By ▲ 0.01 (0.09%)
PAEL 45.39 Increased By ▲ 0.04 (0.09%)
PIAHCLA 30.31 Decreased By ▼ -0.46 (-1.49%)
PIBTL 18.87 Decreased By ▼ -0.19 (-1%)
PPL 248.71 Increased By ▲ 2.76 (1.12%)
PRL 36.29 Increased By ▲ 0.21 (0.58%)
PTC 74.01 Increased By ▲ 1.65 (2.28%)
SEARL 96.13 Decreased By ▼ -0.54 (-0.56%)
SSGC 31.37 Decreased By ▼ -0.30 (-0.95%)
TELE 9.21 Decreased By ▼ -0.06 (-0.65%)
THCCL 68.04 Increased By ▲ 0.23 (0.34%)
TPLP 11.64 Increased By ▲ 0.41 (3.65%)
TREET 25.72 Decreased By ▼ -0.17 (-0.66%)
TRG 67.62 Decreased By ▼ -0.22 (-0.32%)
WAVES 11.25 Increased By ▲ 0.27 (2.46%)
WTL 1.28 No Change ▼ 0.00 (0%)
Markets

S&P 500, Nasdaq hit record highs as Apple crosses $2trn mark

  • S&P 500 touches all-time high for second consecutive session.
  • Nasdaq hits record high for third straight day.
  • Momenta soars after $6.5 bln takeover offer from J&J.
  • Indexes up: Dow 0.20%, S&P 0.19%, Nasdaq 0.29%.
Published Updated
By

The S&P 500 and the Nasdaq indexes hit all-time highs on Wednesday as Apple became the first publicly listed US company to cross $2 trillion in market capitalization, with strong results from retailers Target and Lowe's also lifting sentiment.

Already crowned the most valuable listed company in the world, Apple Inc rose 1.4% to cross the milestone, while providing the biggest support to the three main indexes.

"For this market to sustain all-time high levels we either have to see something develop on the fiscal side, or we would need to see large-cap tech continue to lead," said Yousef Abbasi, global market strategist at StoneX.

The S&P 500 closed at a record level on Tuesday in what has been its fastest recovery ever from a bear market. The Nasdaq recouped its losses from the pandemic selloff two months ago, but the Dow is still nearly 5% below February's record closing high.

However, some market experts were skeptical of the new peaks at a time when volumes are typically weak due to slow summer trading.

"The record high was met without any real fanfare, in the sense that we have low volumes, and not really any strong conviction of the rally ahead," said Peter Cardillo, chief market economist at Spartan Capital Securities in New York.

While trillions of dollars in fiscal and monetary support and a rally in tech-related shares have helped the benchmark surge about 55% from its March lows, the country's economy is struggling to recover from the pandemic shocks.

Minutes from the Federal Reserve's meeting, set for release at 2 p.m. ET (1800 GMT), could offer clues into the central bank's plans for September.

Hopes for another round of fiscal coronavirus aid, after enhanced unemployment benefits expired last month, have been driving US stocks higher. But Democrats and Republicans remain divided on key issues of the bill.

Big-box chain Target Corp jumped 12.3% after posting its best quarterly comparable sales growth while home improvement chain Lowe's Cos Inc also beat estimates for quarterly results.

However, Lowe's shares dipped 0.1%.

At 12:43 p.m. ET, the Dow Jones Industrial Average was up 56.67 points, or 0.20%, at 27,834.74 and the S&P 500 was up 6.53 points, or 0.19%, at 3,396.31. The Nasdaq Composite was up 32.93 points, or 0.29%, at 11,243.77.

Johnson & Johnson said it would buy Momenta Pharmaceuticals Inc for about $6.5 billion to bolster its portfolio of treatments for autoimmune diseases. Momenta shares soared 69.4%.

Gilead Sciences Inc fell 4.1% after the US FDA refused to approve its experimental treatment for rheumatoid arthritis in its current form.

Advancing issues outnumbered decliners by a 1.31-to-1 ratio on the NYSE and by a 1.50-to-1 ratio on the Nasdaq.

The S&P index recorded 25 new 52-week highs and no new low, while the Nasdaq recorded 62 new highs and 18 new lows.

Comments

Comments are closed for this article.